HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection and typing of human papillomaviruses by in situ hybridization with biotinylated oligonucleotide mixtures.

Abstract
The value of biotinylated oligonucleotide probes for screening and typing by in situ hybridization of the most frequent genital human papillomavirus infections (HPVs 6, 11, 16, 18, 31, and 33) was assessed. Optimal hybridization conditions were defined on a panel of paraffin-embedded tissue sections previously characterized with HPV full genome probes. Mixtures of oligonucleotides rather than single oligonucleotides were used to improve sensitivity and specificity. All HPV-positive specimens were detected by the screening mixture with a sensitivity and specificity similar to that of full genome probes. Typing mixtures were highly specific for each HPV type. This study confirms the potential of oligonucleotide probes for detecting and typing HPV infections.
AuthorsM L Jourdan, M Joannes, C Barranger, G Sommé, A Goudeau
JournalJournal of medical virology (J Med Virol) Vol. 45 Issue 3 Pg. 293-9 (Mar 1995) ISSN: 0146-6615 [Print] United States
PMID7775951 (Publication Type: Journal Article)
Chemical References
  • DNA Probes, HPV
  • Biotin
Topics
  • Biotin
  • Cervix Uteri (virology)
  • Condylomata Acuminata (virology)
  • DNA Probes, HPV
  • Female
  • Humans
  • In Situ Hybridization (methods, statistics & numerical data)
  • Papillomaviridae (classification, genetics, isolation & purification)
  • Papillomavirus Infections (virology)
  • Sensitivity and Specificity
  • Tumor Virus Infections (virology)
  • Uterine Cervical Neoplasms (virology)
  • Vulvar Neoplasms (virology)
  • Uterine Cervical Dysplasia (virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: